Medpace Holdings, Inc. Operating Income
Medpace Holdings, Inc. (MEDP) reported Operating Income of $146.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-23
- Medpace Holdings, Inc. operating income (loss) for the quarter ending 2026-06-30 was $146.82M, a 16.22% increase year-over-year.
- Medpace Holdings, Inc. operating income (loss) for the quarter ending 2026-03-31 was $141.50M, a 24.65% increase year-over-year.
- Medpace Holdings, Inc. operating income (loss) for the quarter ending 2025-12-31 was $153.27M, a 22.25% increase year-over-year.
- Medpace Holdings, Inc. operating income (loss) for the quarter ending 2025-09-30 was $141.81M, a 26.31% increase year-over-year.
- Medpace Holdings, Inc. operating income (loss) for fiscal 2025 was $534.93M, a 19.71% increase from fiscal 2024.
- Medpace Holdings, Inc. operating income (loss) for fiscal 2024 was $446.87M, a 32.67% increase from fiscal 2023.
- Medpace Holdings, Inc. operating income (loss) for fiscal 2023 was $336.82M, a 20.86% increase from fiscal 2022.
- Medpace Holdings, Inc. operating income (loss) for fiscal 2022 was $278.70M, a 40.32% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $146.82M 10-Q · filed 2026-07-23 | $288.33M 10-Q · filed 2026-07-23 | $441.60M derived: sum of 3 quarters · filed 2026-07-23 | $583.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $141.50M 10-Q · filed 2026-04-23 | $294.77M derived: sum of 2 quarters · filed 2026-04-23 | $436.58M derived: sum of 3 quarters · filed 2026-04-23 | $562.91M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $153.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $295.08M derived: sum of 2 quarters · filed 2026-02-10 | $421.41M derived: sum of 3 quarters · filed 2026-07-23 | $534.93M 10-K · filed 2026-02-10 |
| 2025-09-30 | $141.81M 10-Q · filed 2025-10-23 | $268.14M derived: sum of 2 quarters · filed 2026-07-23 | $381.67M 10-Q · filed 2025-10-23 | $507.04M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $126.33M 10-Q · filed 2026-07-23 | $239.86M 10-Q · filed 2026-07-23 | $365.24M derived: sum of 3 quarters · filed 2026-07-23 | $477.51M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $113.52M 10-Q · filed 2026-04-23 | $238.90M derived: sum of 2 quarters · filed 2026-04-23 | $351.17M derived: sum of 3 quarters · filed 2026-04-23 | $456.32M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $125.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $237.65M derived: sum of 2 quarters · filed 2026-02-10 | $342.80M derived: sum of 3 quarters · filed 2026-02-10 | $446.87M 10-K · filed 2026-02-10 |
| 2024-09-30 | $112.27M 10-Q · filed 2025-10-23 | $217.42M derived: sum of 2 quarters · filed 2025-10-23 | $321.49M 10-Q · filed 2025-10-23 | $408.81M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $105.15M 10-Q · filed 2025-07-22 | $209.22M 10-Q · filed 2025-07-22 | $296.54M derived: sum of 3 quarters · filed 2026-02-10 | $381.45M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $104.07M 10-Q · filed 2025-04-22 | $191.39M derived: sum of 2 quarters · filed 2026-02-10 | $276.30M derived: sum of 3 quarters · filed 2026-02-10 | $354.69M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $87.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $172.23M derived: sum of 2 quarters · filed 2026-02-10 | $250.62M derived: sum of 3 quarters · filed 2026-02-10 | $336.82M 10-K · filed 2026-02-10 |
| 2023-09-30 | $84.91M 10-Q · filed 2024-10-22 | $163.30M derived: sum of 2 quarters · filed 2024-10-22 | $249.50M 10-Q · filed 2024-10-22 | $325.94M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $78.39M 10-Q · filed 2024-07-23 | $164.60M 10-Q · filed 2024-07-23 | $241.03M derived: sum of 3 quarters · filed 2025-02-11 | $318.86M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $86.20M 10-Q · filed 2024-04-23 | $162.63M derived: sum of 2 quarters · filed 2025-02-11 | $240.46M derived: sum of 3 quarters · filed 2025-02-11 | $300.70M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $76.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $154.26M derived: sum of 2 quarters · filed 2025-02-11 | $214.49M derived: sum of 3 quarters · filed 2025-02-11 | $278.70M 10-K · filed 2025-02-11 |
| 2022-09-30 | $77.83M 10-Q · filed 2023-10-24 | $138.06M derived: sum of 2 quarters · filed 2023-10-24 | $202.27M 10-Q · filed 2023-10-24 | $257.12M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $60.24M 10-Q · filed 2023-07-25 | $124.44M 10-Q · filed 2023-07-25 | $179.29M derived: sum of 3 quarters · filed 2024-02-13 | $233.01M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $64.20M 10-Q · filed 2023-04-25 | $119.06M derived: sum of 2 quarters · filed 2024-02-13 | $172.77M derived: sum of 3 quarters · filed 2024-02-13 | $215.22M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $54.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $108.57M derived: sum of 2 quarters · filed 2024-02-13 | $151.02M derived: sum of 3 quarters · filed 2024-02-13 | $198.62M 10-K · filed 2024-02-13 |
| 2021-09-30 | $53.71M 10-Q · filed 2022-10-25 | $96.16M derived: sum of 2 quarters · filed 2022-10-25 | $143.76M 10-Q · filed 2022-10-25 | $198.75M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $42.45M 10-Q · filed 2022-07-26 | $90.05M 10-Q · filed 2022-07-26 | $145.03M derived: sum of 3 quarters · filed 2023-02-14 | $191.46M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $47.60M 10-Q · filed 2022-04-26 | $102.59M derived: sum of 2 quarters · filed 2023-02-14 | $149.01M derived: sum of 3 quarters · filed 2023-02-14 | $179.14M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $54.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $101.41M derived: sum of 2 quarters · filed 2023-02-14 | $131.54M derived: sum of 3 quarters · filed 2023-02-14 | $167.04M 10-K · filed 2023-02-14 |
| 2020-09-30 | $46.42M 10-Q · filed 2021-10-26 | $76.55M derived: sum of 2 quarters · filed 2021-10-26 | $112.05M 10-Q · filed 2021-10-26 | $148.17M derived: sum of 4 quarters · filed 2021-10-26 |
| 2020-06-30 | $30.13M 10-Q · filed 2021-07-27 | $65.63M 10-Q · filed 2021-07-27 | $101.75M derived: sum of 3 quarters · filed 2021-07-27 | $131.74M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $35.50M 10-Q · filed 2021-04-27 | $71.62M derived: sum of 2 quarters · filed 2021-04-27 | $101.61M derived: sum of 3 quarters · filed 2021-04-27 | $136.87M derived: sum of 4 quarters · filed 2021-04-27 |
| 2019-12-31 | $36.12M 10-K · filed 2020-02-25 | $66.11M derived: sum of 2 quarters · filed 2020-10-27 | $101.37M derived: sum of 3 quarters · filed 2020-10-27 | $127.26M 10-K · filed 2022-02-15 |
| 2019-09-30 | $29.99M 10-Q · filed 2020-10-27 | $65.25M derived: sum of 2 quarters · filed 2020-10-27 | $91.14M 10-Q · filed 2020-10-27 | $121.81M derived: sum of 4 quarters · filed 2020-10-27 |
| 2019-06-30 | $35.26M 10-Q · filed 2020-07-28 | $61.15M 10-Q · filed 2020-07-28 | $91.82M derived: sum of 3 quarters · filed 2020-07-28 | $118.74M derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-03-31 | $25.89M 10-Q · filed 2020-04-29 | $56.56M derived: sum of 2 quarters · filed 2020-04-29 | $83.48M derived: sum of 3 quarters · filed 2020-04-29 | $106.82M derived: sum of 4 quarters · filed 2020-04-29 |
| 2018-12-31 | $30.67M 10-K · filed 2020-02-25 | $57.58M derived: sum of 2 quarters · filed 2020-02-25 | $80.93M derived: sum of 3 quarters · filed 2020-02-25 | $101.05M 10-K · filed 2021-02-16 |
| 2018-09-30 | $26.92M 10-K · filed 2020-02-25 | $50.26M derived: sum of 2 quarters · filed 2020-02-25 | $70.38M 10-Q · filed 2019-10-29 | $85.82M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $23.34M 10-K · filed 2020-02-25 | $43.46M 10-Q · filed 2019-07-30 | $58.90M derived: sum of 3 quarters · filed 2020-02-25 | $76.10M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $20.12M 10-K · filed 2020-02-25 | $35.56M derived: sum of 2 quarters · filed 2020-02-25 | $52.75M derived: sum of 3 quarters · filed 2020-02-25 | $69.03M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $15.44M 10-K · filed 2019-02-26 | $32.63M derived: sum of 2 quarters · filed 2019-02-26 | $48.91M derived: sum of 3 quarters · filed 2019-02-26 | $64.86M 10-K · filed 2020-02-25 |
| 2017-09-30 | $17.20M 10-K · filed 2019-02-26 | $33.48M derived: sum of 2 quarters · filed 2019-02-26 | $49.42M 10-Q · filed 2018-10-30 | $62.31M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $16.28M 10-K · filed 2019-02-26 | $32.22M 10-Q · filed 2018-07-31 | $45.11M derived: sum of 3 quarters · filed 2019-02-26 | $57.73M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $15.94M 10-K · filed 2019-02-26 | $28.83M derived: sum of 2 quarters · filed 2019-02-26 | $41.45M derived: sum of 3 quarters · filed 2019-02-26 | $55.56M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $12.89M 10-K · filed 2018-02-27 | $25.51M derived: sum of 2 quarters · filed 2018-02-27 | $39.62M derived: sum of 3 quarters · filed 2018-02-27 | $52.49M 10-K · filed 2019-02-26 |
| 2016-09-30 | $12.62M 10-K · filed 2018-02-27 | $26.73M derived: sum of 2 quarters · filed 2018-02-27 | $39.60M 10-Q · filed 2017-10-31 | $38.71M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $14.11M 10-K · filed 2018-02-27 | $26.98M 10-Q · filed 2017-08-01 | $26.09M derived: sum of 3 quarters · filed 2018-02-27 | $33.29M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $12.87M 10-K · filed 2018-02-27 | $11.98M derived: sum of 2 quarters · filed 2018-02-27 | $19.18M derived: sum of 3 quarters · filed 2018-02-27 | $27.04M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$889.00K 10-K · filed 2017-02-28 | $6.31M derived: sum of 2 quarters · filed 2017-02-28 | $14.17M derived: sum of 3 quarters · filed 2017-02-28 | $20.56M 10-K · filed 2018-02-27 |
| 2015-09-30 | $7.20M 10-K · filed 2017-02-28 | $15.06M derived: sum of 2 quarters · filed 2017-02-28 | $21.45M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $7.87M 10-K · filed 2017-02-28 | $14.26M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $6.39M 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $2.45M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |